1M7 Stock Overview
A neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Cambridge Cognition Holdings Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.39 |
| 52 Week High | UK£0.69 |
| 52 Week Low | UK£0.32 |
| Beta | 0.83 |
| 1 Month Change | 22.15% |
| 3 Month Change | -11.06% |
| 1 Year Change | -31.68% |
| 3 Year Change | -73.19% |
| 5 Year Change | n/a |
| Change since IPO | -32.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1M7 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -4.0% | 0.6% | -0.2% |
| 1Y | -31.7% | -21.0% | 7.0% |
Return vs Industry: 1M7 underperformed the German Healthcare Services industry which returned -21% over the past year.
Return vs Market: 1M7 underperformed the German Market which returned 7% over the past year.
Price Volatility
| 1M7 volatility | |
|---|---|
| 1M7 Average Weekly Movement | 8.7% |
| Healthcare Services Industry Average Movement | 6.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1M7's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 1M7's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 119 | Rob Baker | www.cambridgecognition.com |
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides cognitive kit for detecting fluctuations in brain health.
Cambridge Cognition Holdings Plc Fundamentals Summary
| 1M7 fundamental statistics | |
|---|---|
| Market cap | €18.59m |
| Earnings (TTM) | -€1.59m |
| Revenue (TTM) | €15.78m |
1.2x
P/S Ratio-11.7x
P/E RatioIs 1M7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1M7 income statement (TTM) | |
|---|---|
| Revenue | UK£13.08m |
| Cost of Revenue | UK£2.52m |
| Gross Profit | UK£10.56m |
| Other Expenses | UK£11.88m |
| Earnings | -UK£1.32m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | 80.77% |
| Net Profit Margin | -10.07% |
| Debt/Equity Ratio | 92.5% |
How did 1M7 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 00:23 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cambridge Cognition Holdings Plc is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Julie Simmonds | CGS International |
| Paul Richards | Dowgate Capital Stockbrokers Limited |
| Lorne Daniel | Dowgate Capital Stockbrokers Limited |